VIROFOB 245mg film-coated tablets medication leaflet

J05AF07 tenofovir disoproxil fumarate • Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors

Tenofovir disoproxil fumarate is an antiviral medication used for the treatment of HIV-1 infection and chronic hepatitis B. It works by inhibiting reverse transcriptase, an enzyme essential for viral replication, thereby reducing the viral load in the body.

The medication is taken orally, usually once daily, as directed by a doctor. It is important for patients to follow the prescribed dosage and not discontinue treatment without consulting their doctor.

Patients should be monitored for potential side effects, such as nausea, diarrhea, or headaches. Regular check-ups are also important to monitor kidney function and bone density.

Common side effects include nausea, diarrhea, headaches, and fatigue. In rare cases, severe reactions such as kidney failure or lactic acidosis may occur. Patients should be informed of these risks before starting treatment.

General data about VIROFOB 245mg

Substance: tenofovir disoproxil fumarate

Date of last drug list: 10-04-2026

Commercial code: W62771001

Concentration: 245mg

Pharmaceutical form: film-coated tablets

Quantity: 30

Product type: generic

Price: 576.68 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: REMEDICA LTD. - CIPRU

Holder: ALVOGEN IPCO S.AR.L. - LUXEMBURG

Number: 13853/2021/01

Shelf life: 4 years-after packing for marketing;after the first opening of the bottle-30 days

Compensation lists for VIROFOB 245mg ALVOGEN

G4 (C1) - Chronic hepatitis of viral etiology (HBV, HCV)

Price

Copayment

Patient

576.68 RON

576.68 RON

0.00 RON

NHP 1.A (C2) - People with HIV/AIDS and post-exposure treatment

Price

Copayment

Patient

576.68 RON

576.68 RON

0.00 RON